Preclinical studies from our laboratory have demonstrated that anabolic PTH decreases both the tumor engraftment rate and the incidence of spontaneous breast cancer metastases to bone in orthotopic models of both human and murine breast cancer tumors and prolongs survival in mice (17). This evidence concerns the gene PTH and breast cancer.